February 2, 2018 - It is with a mixture of emotion that we must inform you that Interceder will cease its service over the coming weeks. For nearly a decade we have been helping you find relevant information across thousands of news and social sources, to keep you abreast of the latest news. We’re a small team of two who have run Interceder outside of our regular day jobs and are intensely proud of what we managed to accomplish over the years. Through a lack of time to maintain the site and growing costs associated with acquiring, indexing, analysing and hosting content we will be shutting down Interceder for good. All things reach a natural end, but we could not be more grateful for the way you made us part of your day, so instead of saying goodbye we would just like to say thank you!

Leerink Partners

Latest articles

13d
WPXI Pittsburgh
Pharmaceutical company touts 'breakthrough' cancer treatmentdrug's profitability as they further demonstrate its benefits, the company said
WPXI Pittsburgh / Posted 13 days ago
drug's profitability as they further demonstrate its benefits, the company said. However, Seamus Fernandez, an analyst at Leerink Partners, pointed out that it remains to be seen whether combining Opdivo with Yervoy provides better results than... Read more
10 related articles
14d
The Palm Beach Post
Pharmaceutical company touts 'breakthrough' cancer treatmentdrug's profitability as they further demonstrate its benefits, the company said
The Palm Beach Post / Posted 14 days ago
drug's profitability as they further demonstrate its benefits, the company said. However, Seamus Fernandez, an analyst at Leerink Partners, pointed out that it remains to be seen whether combining Opdivo with Yervoy provides better results than... Read more
10 related articles
14d
Springfield News-Sun
Pharmaceutical company touts 'breakthrough' cancer treatmentdrug's profitability as they further demonstrate its benefits, the company said
Springfield News-Sun / Posted 14 days ago
drug's profitability as they further demonstrate its benefits, the company said. However, Seamus Fernandez, an analyst at Leerink Partners, pointed out that it remains to be seen whether combining Opdivo with Yervoy provides better results than... Read more
10 related articles
14d
Dayton Daily News
Pharmaceutical company touts 'breakthrough' cancer treatmentdrug's profitability as they further demonstrate its benefits, the company said
Dayton Daily News / Posted 14 days ago
drug's profitability as they further demonstrate its benefits, the company said. However, Seamus Fernandez, an analyst at Leerink Partners, pointed out that it remains to be seen whether combining Opdivo with Yervoy provides better results than... Read more
10 related articles
14d
WPXI Pittsburgh
Pharmaceutical company touts 'breakthrough' cancer treatmentdrug's profitability as they further demonstrate its benefits, the company said
WPXI Pittsburgh / Posted 14 days ago
drug's profitability as they further demonstrate its benefits, the company said. However, Seamus Fernandez, an analyst at Leerink Partners, pointed out that it remains to be seen whether combining Opdivo with Yervoy provides better results than... Read more
10 related articles
14d
WSOC-TV Charlotte
Pharmaceutical company touts 'breakthrough' cancer treatmentdrug's profitability as they further demonstrate its benefits, the company said
WSOC-TV Charlotte / Posted 14 days ago
drug's profitability as they further demonstrate its benefits, the company said. However, Seamus Fernandez, an analyst at Leerink Partners, pointed out that it remains to be seen whether combining Opdivo with Yervoy provides better results than... Read more
10 related articles
14d
The Hamilton Journal News
Pharmaceutical company touts 'breakthrough' cancer treatmentdrug's profitability as they further demonstrate its benefits, the company said
The Hamilton Journal News / Posted 14 days ago
drug's profitability as they further demonstrate its benefits, the company said. However, Seamus Fernandez, an analyst at Leerink Partners, pointed out that it remains to be seen whether combining Opdivo with Yervoy provides better results than... Read more
10 related articles
14d
WFTV 9 Orlando
Pharmaceutical company touts 'breakthrough' cancer treatmentdrug's profitability as they further demonstrate its benefits, the company said
WFTV 9 Orlando / Posted 14 days ago
drug's profitability as they further demonstrate its benefits, the company said. However, Seamus Fernandez, an analyst at Leerink Partners, pointed out that it remains to be seen whether combining Opdivo with Yervoy provides better results than... Read more
10 related articles
14d
ajc.com
This pharmaceutical company says it’s found a 'breakthrough' lung cancer treatmentincrease the drug's profitability, as they further demonstrate its benefits. Ho
ajc.com / Posted 14 days ago
increase the drug's profitability, as they further demonstrate its benefits. However, Seamus Fernandez, an analyst at Leerink Partners, pointed out that it remains to be seen whether combining Opdivo with Yervoy provides better results than... Read more
10 related articles
m
The Courier Express Newspapers
Initial public offerings scheduled to debut next weekof Jan. 22: ARMO Biosciences - Redwood City, Calif., 6.7 million shares, price
The Courier Express Newspapers / Posted 1 months ago
of Jan. 22: ARMO Biosciences - Redwood City, Calif., 6.7 million shares, priced $14-$16, managed by Jefferies/Leerink Partners. Proposed Nasdaq symbol ARMO. Business: Developing immunotherapies targeting various cancers and solid... Read more

In this news